Abstract
One of the well-studied older molecules, quercetin, is found in large quantities in many fruits and vegetables. Natural anti-oxidant quercetin has demonstrated numerous pharmacological properties in preclinical and clinical research, including anti-inflammatory and anti-cancer effects. Due to its ability to control cell signaling pathways, including NF-κB, p53, activated protein-1 (AP-1), STAT3, and epidermal growth response-1 (Egr-1), which is essential in the initiation and proliferation of cancer, it has gained a lot of fame as an anticancer molecule. Recent research suggests that using nanoformulations can help quercetin to overcome its hydrophobicity while also enhancing its stability and cellular bioavailability both in vitro and in vivo. The main aim of this review is to focus on the comprehensive insights of several nanoformulations, including liposomes, nano gels, micelles, solid lipid nanoparticles (SLN), polymer nanoparticles, gold nanoparticles, and cyclodextrin complexes, to transport quercetin for application in cancer.
Similar content being viewed by others
Data availability
This document includes citations for all the data that were analyzed throughout the literature review.
References
Abadi AJ, Mirzaei S, Mahabady MK et al (2022) Curcumin and its derivatives in cancer therapy: potentiating antitumor activity of cisplatin and reducing side effects. Phytother Res 36:189–213
Aggarwal V, Tuli HS, Thakral F et al (2020) Molecular mechanisms of action of hesperidin in cancer: recent trends and advancements. Exp Biol Med 245:486–497
Aghapour F, Moghadamnia AA, Nicolini A et al (2018) Quercetin conjugated with silica nanoparticles inhibits tumor growth in MCF-7 breast cancer cell lines. Biochem Biophys Res Commun 500:860–865
Almatroodi SA, Alsahli MA, Almatroudi A et al (2021) Potential therapeutic targets of quercetin, a plant flavonol, and its role in the therapy of various types of cancer through the modulation of various cell signaling pathways. Molecules 26:1315
Asgharian P, Tazekand AP, Hosseini K et al (2022) Potential mechanisms of quercetin in cancer prevention: focus on cellular and molecular targets. Cancer Cell Int 22:257
Askar MA, El-Nashar HA, Al-Azzawi MA, Rahman SSA, Elshawi OE (2022) Synergistic effect of quercetin magnetite nanoparticles and targeted radiotherapy in treatment of breast cancer. Breast Cancer: Basic Clin Res 16:11782234221086728
Baksi R, Singh DP, Borse SP, Rana R, Sharma V, Nivsarkar M (2018) In vitro and in vivo anticancer efficacy potential of quercetin loaded polymeric nanoparticles. Biomed Pharmacother 106:1513–1526
Balakrishnan S, Mukherjee S, Das S et al (2017) Gold nanoparticles–conjugated quercetin induces apoptosis via inhibition of EGFR/PI3K/Akt–mediated pathway in breast cancer cell lines (MCF-7 and MDA-MB-231). Cell Biochem Funct 35:217–231
Barani M, Hajinezhad MR, Zargari F et al (2023) Preparation, characterization, cytotoxicity and pharmacokinetics of niosomes containing gemcitabine: in vitro, in vivo, and simulation studies. J Drug Deliv Sci Technol 84:104505
Bentz AB (2017) A review of quercetin: chemistry, antioxident properties, and bioavailability. J Young Investig
Bhattacharya T, Shin GH, Kim JT (2023) Carbon dots: opportunities and challenges in cancer therapy. Pharmaceutics 15:1019
Biswas S, Kumari P, Lakhani PM, Ghosh B (2016) Recent advances in polymeric micelles for anti-cancer drug delivery. Eur J Pharm Sci 83:184–202
Cai X, Fang Z, Dou J, Yu A, Zhai G (2013) Bioavailability of quercetin: problems and promises. Curr Med Chem 20:2572–2582
Cheng X, Yan H, Pang S et al (2022) Liposomes as multifunctional nano-carriers for medicinal natural products. Front Chem 10:963004
Comfort C, Garrastazu G, Pozzoli M, Sonvico F (2015) Opportunities and challenges for the nasal administration of nanoemulsions. Curr Top Med Chem 15:356–368
Das SS, Dubey AK, Verma PRP, Singh SK, Singh SK (2022) Therapeutic potential of quercetin-loaded nanoemulsion against experimental visceral leishmaniasis: in vitro/ex vivo studies and mechanistic insights. Mol Pharm 19:3367–3384
David AVA, Arulmoli R, Parasuraman S (2016) Overviews of biological importance of quercetin: a bioactive flavonoid. Pharmacogn Rev 10:84
de Oliveira PR, Hoffmann S, Pereira S, Goycoolea FM, Schmitt CC, Neumann MG (2018) Self-assembled amphiphilic chitosan nanoparticles for quercetin delivery to breast cancer cells. Eur J Pharm Biopharm 131:203–210
Deldar Abad Paskeh M, Asadi S, Zabolian A et al (2021) Targeting cancer stem cells by dietary agents: an important therapeutic strategy against human malignancies. Int J Mol Sci 22:11669
Dhanaraj T, Mohan M, Arunakaran J (2021) Quercetin attenuates metastatic ability of human metastatic ovarian cancer cells via modulating multiple signaling molecules involved in cell survival, proliferation, migration and adhesion. Arch Biochem Biophys 701:108795
Dian L, Yu E, Chen X et al (2014) Enhancing oral bioavailability of quercetin using novel soluplus polymeric micelles. Nanoscale Res Lett 9:1–11
Elbarbry F, Ung A, Abdelkawy K (2017) Studying the inhibitory effect of quercetin and thymoquinone on human cytochrome P450 enzyme activities. Pharmacogn Mag 13:S895
Elsayed AM, Sherif NM, Hassan NS, Althobaiti F, Hanafy NA, Sahyon HA (2021) Novel quercetin encapsulated chitosan functionalized copper oxide nanoparticles as anti-breast cancer agent via regulating p53 in rat model. Int J Biol Macromol 185:134–152
Ersoz M, Erdemir A, Derman S, Arasoglu T, Mansuroglu B (2020) Quercetin-loaded nanoparticles enhance cytotoxicity and antioxidant activity on C6 glioma cells. Pharm Dev Technol 25:757–766
Ferry DR, Smith A, Malkhandi J et al (1996) Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin Cancer Res 2:659–668
Formica J, Regelson W (1995) Review of the biology of quercetin and related bioflavonoids. Food Chem Toxicol 33:1061–1080
Gang W, Jie WJ, Ping ZL et al (2012) Liposomal quercetin: evaluating drug delivery in vitro and biodistribution in vivo. Expert Opin Drug Deliv 9:599–613
Ganthala PD, Alavala S, Chella N, Andugulapati SB, Bathini NB, Sistla R (2022) Co-encapsulated nanoparticles of erlotinib and quercetin for targeting lung cancer through nuclear EGFR and PI3K/AKT inhibition. Colloids Surf, B 211:112305
Gao Y, Li C, Xue T et al (2023) Quercetin mediated TET1 expression through microRNA-17 induced cell apoptosis in melanoma cells. Biochem Genet 61:762–777
Gates MA, Tworoger SS, Hecht JL, De Vivo I, Rosner B, Hankinson SE (2007) A prospective study of dietary flavonoid intake and incidence of epithelial ovarian cancer. Int J Cancer 121:2225–2232
Gibellini L, Pinti M, Nasi M, et al. (2011) Quercetin and cancer chemoprevention. Evidence-Based Complementary and Alternative Medicine 2011:15. https://doi.org/10.1093/ecam/neq053
Gokhale JP, Mahajan HS, Surana SJ (2019) Quercetin loaded nanoemulsion-based gel for rheumatoid arthritis: in vivo and in vitro studies. Biomed Pharmacother 112:108622
Graefe E, Derendorf H, Veit M (1999) Pharmacokinetics and bioavailability of the flavonol quercetin in humans. Int J Clin Pharmacol Ther 37:219–233
Guan F, Wang Q, Bao Y, Chao Y (2021) Anti-rheumatic effect of quercetin and recent developments in nano formulation. RSC Adv 11:7280–7293
Guan H, Zhang W, Liu H et al (2023) Quercetin induces apoptosis in HepG2 cells via directly interacting with YY1 to disrupt YY1-p53 interaction. Metabolites 13:229
Gugler R, Leschik M, Dengler H (1975) Disposition of quercetin in man after single oral and intravenous doses. Eur J Clin Pharmacol 9:229–234
Hai Y, Zhang Y, Liang Y et al (2020) Advance on the absorption, metabolism, and efficacy exertion of quercetin and its important derivatives: absorption, metabolism and function of quercetin. Food Front 1:420–434
Hsieh Y-S, Yang S-F, Sethi G, Hu D-N (2015) Natural bioactives in cancer treatment and prevention. BioMed Res Int 2015:1. https://doi.org/10.1155/2015/182835
Huang M, Su E, Zheng F, Tan C (2017) Encapsulation of flavonoids in liposomal delivery systems: the case of quercetin, kaempferol and luteolin. Food Funct 8:3198–3208
Hussain Y, Mirzaei S, Ashrafizadeh M et al (2021) Quercetin and its nano-scale delivery systems in prostate cancer therapy: paving the way for cancer elimination and reversing chemoresistance. Cancers 13:1602
Joshi H, Verma A, Soni DK (2019) Impact of microbial genomics approaches for novel antibiotic target. Microbial Genom Sustain Agroecosyst 2:75–88
Joshi H, Kumar G, Tuli HS, Mittal S (2022) Inhibition of cancer cell metastasis by nanotherapeutics: current achievements and future trends. Nanotherapeutics in cancer. Jenny Stanford Publishing, New York, pp 161–209
Joshi H, Gupta DS, Abjani NK, Kaur G, Mohan CD, Kaur J, Aggarwal D, Rani I, Ramniwas S, Abdulabbas HS, Gupta M (2023) Genistein: a promising modulator of apoptosis and survival signaling in cancer. Naunyn-Schmiedeberg’s Arch Pharmacol:1–18. https://doi.org/10.1007/s00210-023-02550-1
Kashyap D, Mittal S, Sak K, Singhal P, Tuli HS (2016) Molecular mechanisms of action of quercetin in cancer: recent advances. Tumor Biol 37:12927–12939
Kee J-Y, Han Y-H, Kim D-S et al (2016) Inhibitory effect of quercetin on colorectal lung metastasis through inducing apoptosis, and suppression of metastatic ability. Phytomedicine 23:1680–1690
Khan MM, Torchilin VP (2022) Recent trends in nanomedicine-based strategies to overcome multidrug resistance in tumors. Cancers 14:4123
Kim Y, Oh KT, Youn YS, Lee ES (2022) pH-sensitive twin liposomes containing quercetin and laccase for tumor therapy. Biomacromol 23:3688–3697
Klein S, Luchs T, Leng A, Distel LV, Neuhuber W, Hirsch A (2020) Encapsulation of hydrophobic drugs in shell-by-shell coated nanoparticles for radio-and chemotherapy—an in vitro study. Bioengineering 7:126
Kumar M, Sharma G, Misra C et al (2018) N-desmethyl tamoxifen and quercetin-loaded multiwalled CNTs: a synergistic approach to overcome MDR in cancer cells. Mater Sci Eng, C 89:274–282
Lan J-S, Liu L, Zeng R-F et al (2021) Tumor-specific carrier-free nanodrugs with GSH depletion and enhanced ROS generation for endogenous synergistic anti-tumor by a chemotherapy-photodynamic therapy. Chem Eng J 407:127212
Li B, Wang W, Zhao L et al (2023) Multifunctional AIE nanosphere-based “Nanobomb” for trimodal imaging-guided photothermal/photodynamic/pharmacological therapy of drug-resistant bacterial infections. ACS Nano 17:4601–4618
Lin R, Piao M, Song Y, Liu C (2020) Quercetin suppresses AOM/DSS-induced colon carcinogenesis through its anti-inflammation effects in mice. J Immunol Res 2020:1–10
Luo C-l, Liu Y-q, Wang P et al (2016) The effect of quercetin nanoparticle on cervical cancer progression by inducing apoptosis, autophagy and anti-proliferation via JAK2 suppression. Biomed Pharmacother 82:595–605
Men K, Duan X, Wei Wei X et al (2014) Nanoparticle-delivered quercetin for cancer therapy. Anticancer Agents Med Chem. 14:826–832
Mirzaei A, Deyhimfar R, Azodian Ghajar H, Mashhadi R, Noori M, Dialameh H, Aghsaeifard Z, Aghamir SM (2023) Quercetin can be a more reliable treatment for metastatic prostate cancer than the localized disease: an in vitro study. J Cell Molec Med. https://doi.org/10.1111/jcmm.17783
Mohammed HA, Sulaiman GM, Anwar SS et al (2021) Quercetin against MCF7 and CAL51 breast cancer cell lines: apoptosis, gene expression and cytotoxicity of nano-quercetin. Nanomedicine 16:1937–1961
Mustafa IF, Hussein MZ (2020) Synthesis and technology of nanoemulsion-based pesticide formulation. Nanomaterials 10:1608
Nguyen LT, Lee Y-H, Sharma AR et al (2017) Quercetin induces apoptosis and cell cycle arrest in triple-negative breast cancer cells through modulation of Foxo3a activity. Korean J Physiol Pharmacol 21:205
Niazvand F, Orazizadeh M, Khorsandi L, Abbaspour M, Mansouri E, Khodadadi A (2019) Effects of quercetin-loaded nanoparticles on MCF-7 human breast cancer cells. Medicina 55:114
Paez-Ribes M, González-Gualda E, Doherty GJ, Muñoz-Espín D (2019) Targeting senescent cells in translational medicine. EMBO Mol Med 11:e10234
Pan H-C, Jiang Q, Yu Y, Mei J-P, Cui Y-K, Zhao W-J (2015) Quercetin promotes cell apoptosis and inhibits the expression of MMP-9 and fibronectin via the AKT and ERK signalling pathways in human glioma cells. Neurochem Int 80:60–71
Paranthaman S, Uthaiah CA, Osmani RAM et al (2022) Anti-proliferative potential of quercetin loaded polymeric mixed micelles on rat C6 and human U87MG glioma cells. Pharmaceutics 14:1643
Patra A, Satpathy S, Shenoy AK, Bush JA, Kazi M, Hussain MD (2018) Formulation and evaluation of mixed polymeric micelles of quercetin for treatment of breast, ovarian, and multidrug resistant cancers. Int J Nanomed 13:2869
Pinheiro R, Granja A, Loureiro JA et al (2020) Quercetin lipid nanoparticles functionalized with transferrin for Alzheimer’s disease. Eur J Pharm Sci 148:105314
Pradhan A, Kumari A, Srivastava R, Panda D (2019) Quercetin encapsulated biodegradable plasmonic nanoparticles for photothermal therapy of hepatocellular carcinoma cells. ACS Appl Bio Mater 2:5727–5738
Rahdar A, Hajinezhad MR, Sargazi S et al (2022) Pluronic F127/carfilzomib-based nanomicelles as promising nanocarriers: synthesis, characterization, biological, and in silico evaluations. J Mol Liq 346:118271
Rashedi J, Haghjo AG, Abbasi MM et al (2019) Anti-tumor effect of quercetin loaded chitosan nanoparticles on induced colon cancer in wistar rats. Adv Pharm Bull 9:409
Roshanazadeh M, Rezaei HB, Rashidi M (2021) Quercetin synergistically potentiates the anti-metastatic effect of 5-fluorouracil on the MDA-MB-231 breast cancer cell line. Iran J Basic Med Sci 24:928
Sadhukhan P, Kundu M, Chatterjee S et al (2019) Targeted delivery of quercetin via pH-responsive zinc oxide nanoparticles for breast cancer therapy. Mater Sci Eng, C 100:129–140
Sak K (2014) Site-specific anticancer effects of dietary flavonoid quercetin. Nutr Cancer 66:177–193
Sak K (2022) Anticancer action of plant products: changing stereotyped attitudes. Explor Target Anti-Tumor Ther 3:423
Salehi B, Machin L, Monzote L et al (2020) Therapeutic potential of quercetin: new insights and perspectives for human health. ACS Omega 5:11849–11872
Sánchez-López E, Guerra M, Dias-Ferreira J et al (2019) Current applications of nanoemulsions in cancer therapeutics. Nanomaterials (Basel) 9(6):821
Serri C, Quagliariello V, Iaffaioli RV et al (2019) Combination therapy for the treatment of pancreatic cancer through hyaluronic acid-decorated nanoparticles loaded with quercetin and gemcitabine: a preliminary in vitro study. J Cell Physiol 234:4959–4969
Shahidi S, Rostamizadeh K, Fathi M, Nedaei K, Ramazani A (2022) Combination of quercetin or/and siRNA-loaded DDAB-mPEG-PCL hybrid nanoparticles reverse resistance to regorafenib in colon cancer cells. BMC Complement Med Ther 22:1–13
Shawky S, Makled S, Awaad A, Boraie N (2022) Quercetin loaded cationic solid lipid nanoparticles in a mucoadhesive in situ gel—a novel intravesical therapy tackling bladder cancer. Pharmaceutics 14:2527
Shitole AA, Sharma N, Giram P et al (2020) LHRH-conjugated, PEGylated, poly-lactide-co-glycolide nanocapsules for targeted delivery of combinational chemotherapeutic drugs docetaxel and quercetin for prostate cancer. Mater Sci Eng, C 114:111035
Simon AT, Dutta D, Chattopadhyay A, Ghosh SS (2021) Quercetin-loaded luminescent hydroxyapatite nanoparticles for theranostic application in monolayer and spheroid cultures of cervical cancer cell line in vitro. ACS Appl Bio Mater 4:4495–4506
Son H-K, Kim D (2023) Quercetin induces cell cycle arrest and apoptosis in YD10B and YD38 oral squamous cell carcinoma cells. Asian Pac J Cancer Prevent: APJCP 24:283
Stoyanova N, Spasova M, Manolova N, Rashkov I, Georgieva A, Toshkova R (2020) Antioxidant and antitumor activities of novel quercetin-loaded electrospun cellulose acetate/polyethylene glycol fibrous materials. Antioxidants 9:232
Sun X, Li Y, Xu L et al (2020) Heparin coated meta-organic framework co-delivering doxorubicin and quercetin for effective chemotherapy of lung carcinoma. J Int Med Res 48:0300060519897185
Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249
Tang L, Li K, Zhang Y et al (2020) Quercetin liposomes ameliorate streptozotocin-induced diabetic nephropathy in diabetic rats. Sci Rep 10:2440
Tuli HS, Joshi H, Vashishth K et al (2023) Chemopreventive mechanisms of amentoflavone: recent trends and advancements. Naunyn Schmiedebergs Arch Pharmacol 396:865–876
Ulusoy HG, Sanlier N (2020) A minireview of quercetin: from its metabolism to possible mechanisms of its biological activities. Crit Rev Food Sci Nutr 60:3290–3303
Vaz GR, Clementino A, Bidone J et al (2020) Curcumin and quercetin-loaded nanoemulsions: physicochemical compatibility study and validation of a simultaneous quantification method. Nanomaterials 10:1650
Vinayak M, Maurya AK (2019) Quercetin loaded nanoparticles in targeting cancer: recent development. Anticancer Agents Med Chem 19:1560–1576
Wang Y, Yu H, Wang S et al (2021) Targeted delivery of quercetin by nanoparticles based on chitosan sensitizing paclitaxel-resistant lung cancer cells to paclitaxel. Mater Sci Eng, C 119:111442
Wu Q, Deng S, Li L et al (2013) Biodegradable polymeric micelle-encapsulated quercetin suppresses tumor growth and metastasis in both transgenic zebrafish and mouse models. Nanoscale 5:12480–12493
Xiao X, Shi D, Liu L et al (2011) Quercetin suppresses cyclooxygenase-2 expression and angiogenesis through inactivation of P300 signaling. PLoS ONE 6:e22934
Xiao J, Zhang B, Yin S, Xie S, Huang K, Wang J, Yang W, Liu H, Zhang G, Liu X, Li Y (2022) Quercetin induces autophagy-associated death in HL-60 cells through CaMKKβ/AMPK/mTOR signal pathway. Acta Biochimica et Biophysica Sinica 54(9):1244. https://doi.org/10.3724/abbs.2022117
Yadav N, Tripathi AK, Parveen A (2022) PLGA-quercetin nano-formulation inhibits cancer progression via mitochondrial dependent caspase-3, 7 and independent FoxO1 activation with concomitant PI3K/AKT suppression. Pharmaceutics 14:1326
Yang F, Jiang X, Song L et al (2016) Quercetin inhibits angiogenesis through thrombospondin-1 upregulation to antagonize human prostate cancer PC-3 cell growth in vitro and in vivo. Oncol Rep 35:1602–1610
Zang X, Cheng M, Zhang X, Chen X (2021) Quercetin nanoformulations: a promising strategy for tumor therapy. Food Funct 12:6664–6681
Zhao X, Wang Q, Yang S et al (2016) Quercetin inhibits angiogenesis by targeting calcineurin in the xenograft model of human breast cancer. Eur J Pharmacol 781:60–68
Zhu S, Yu W, Bi L et al (2022) Quercetin induces apoptosis of human breast cancer cells by activiting PTEN and inhibiting PI3K/AKT and JNK signaling pathways. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 38:714–720
Acknowledgements
Dr. T.S., would like to acknowledge ICMR-DHR, Government of India (ICMR-DHR Young Scientist Fellowship, F.NO: R. 12014/29/2022/HR), and college Research and Development Cell (RDC) Scheme (File no. HRC/RDC/2021/RP/13). We would also like to acknowledge Dr. Hadi Sajid Abdulabbas for his general help in this manuscript.
Author information
Authors and Affiliations
Contributions
H.S.T., H.J., D.S.G., G.K., T.S., S.R., K.S., and D.A. conceived the conceptualization, methodology, validation, and writing—review. M.G. and H.S.T. performed the formal analysis and resources. A.K.S. did the data curation and editing. R.S.C. contributed to revise the manuscript. All authors have read and agreed to the published version of the manuscript. The authors confirm that no paper mill and artificial intelligence was used.
Corresponding author
Ethics declarations
Ethics approval
Not applicable.
Consent to participate
Not applicable.
Consent for publication
All authors have their consent to publish.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Joshi, H., Gupta, D.S., Kaur, G. et al. Nanoformulations of quercetin for controlled delivery: a review of preclinical anticancer studies. Naunyn-Schmiedeberg's Arch Pharmacol 396, 3443–3458 (2023). https://doi.org/10.1007/s00210-023-02625-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-023-02625-z